Locations
New York, NY, USA · Manhattan, New York, NY, USA
industry
Biotechnology · Data and Analytics · DeepTech · Design · Health
Size
51-200 employees
Stage
Series C+
founded in
2021
Precision Neuroscience is a biotech company focused on developing life-changing brain-computer interface technology. Their flagship product, the Layer 7 Cortical Interface, is a minimally invasive implant designed to connect the brain to digital devices without damaging brain tissue. The company aims to restore independence to severely paralyzed individuals and is exploring applications in stroke rehabilitation and refractory depression. Founded in 2021, Precision has made significant strides in clinical partnerships and product development, with plans to launch their first commercial product by 2025. Their innovative approach and commitment to patient safety position them as a leader in the emerging field of neural technology.
Something looks off?